secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001023024-25-000113
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharmaceuticals names Thomas J. Haughey as new Chairman; Patrick Walsh to retire at 2026 annual meeting
--------------------------------------------------------------------------------

- Patrick D. Walsh will not seek re-election as director and steps down as Chairman; no disagreement with board or management.
- Thomas J. Haughey elected Chairman; he has served on the board since May 2018.
- Jeanne A. Thoma replaces Haughey as Chair of Audit and Finance Committee; Haughey remains on the committee.
- Walsh's retirement effective after the 2026 Annual Meeting of Stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000102302425000113/0001023024-25-000113-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000102302425000113/ani-20251124.htm
  HTML page:      https://secwatch.observer/filing/0001023024-25-000113

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer